Canadian Healthtech Linda Lifetech Announces Partnership with Mila to Advance AI in Breast Cancer Prevention and Diagnosis

Mila and Linda Lifetech logos

MONTREAL, November 14, 2023 – Linda Lifetech, an artificial-intelligence (AI) driven healthtech company specializing in women's health, is thrilled to announce its strategic partnership with Mila - Quebec AI Institute, to advance the development of their cutting-edge breast cancer detection solution. This collaboration aims to accelerate breast cancer prevention and diagnosis.

Headquartered in Toronto with a presence in Brazil, Linda Lifetech has developed non-invasive technology and software, designed to assist in the early detection of suspicious breast lesions. 

Linda Lifetech employs AI to analyze thermographic images, enabling quick, low cost, non-invasive, and painless breast examinations that do not involve radiation.  This innovative device, capable of detecting anomalies in the early stages, becomes a crucial tool for breast cancer screening and early detection. 

Breast cancer remains the most common cancer in women worldwide and the leading cause of death among women, especially in developed countries.

“Mila is delighted by this new collaboration with Linda Lifetech, which will aim to develop innovative, AI-driven breast cancer detection technology. This partnership with Linda Lifetech represents an opportunity to improve the accessibility of critical women’s health services by making it more easily available and practical,” said Stéphane Létourneau, Executive Vice President of Mila.

"Breast cancer is a global public health problem, and we need swift advancements in clinical outcomes. This partnership with  Mila is very strategic for us; our collaborative efforts have the potential to introduce fresh capabilities to our product, fostering new avenues for growth," explained Rubens Fernando Mendrone, Founder and Chief Executive Officer of Linda Lifetech.


About Linda Lifetech


Founded in 2019, Linda Lifetech is a pioneering AI healthtech company that uses artificial intelligence for the early detection of suspicious breast lesions. The company is based in Toronto and holds approval from Anvisa, the Brazilian Health Authority Agency. For more information, visit:


About Mila


Founded by Professor Yoshua Bengio of the University of Montreal, Mila is a research institute in artificial intelligence that now brings together over 1,200 specialized researchers in machine learning. Based in Montreal, Mila's mission is to be a global center for scientific advancements that inspire innovation and the growth of AI for the benefit of all. Mila is a globally recognized non-profit organization for its significant contributions to deep learning, especially in the fields of language modeling, automatic translation, object recognition, and generative models. For more information, visit